Abbott and AbbVie Named to S&P Dividend Aristocrats Indices

         Abbott and AbbVie Named to S&P Dividend Aristocrats Indices

PR Newswire

ABBOTT PARK, Ill., Jan. 21, 2013

ABBOTT PARK, Ill., Jan. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) has once
again been named to the S&P 500 Dividend Aristocrats and S&P High Yield
Dividend Aristocrats Indices.

The S&P 500 Dividend Aristocrats comprises companies in the S&P 500 that have
increased dividends every year for the past 25 consecutive years. The S&P High
Yield Dividend Aristocrats includes companies within the S&P Composite 1500
with 20 straight years of dividend increases. Abbott has increased its
dividend payout for 40 consecutive years.

Abbott's former research-based pharmaceutical business, which became the
independent biopharmaceutical company AbbVie on Jan. 1, 2013, was also named
to both lists based on the history of the combined companies' dividend record.

About Abbott

Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of
healthcare.With a portfolio of leading, science-based offerings in
diagnostics, medical devices, nutritionals and branded generic
pharmaceuticals, Abbott serves people in more than 150 countries and employs
approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

SOURCE Abbott

Website: http://www.abbott.com
Contact: Media, Scott Stoffel, +1-847-936-9502; Financial, Brian Yoor,
+1-847-937-6343
 
Press spacebar to pause and continue. Press esc to stop.